Dow Inc. (DOW) Rises As Market Takes a Dip: Key Facts

Dow Inc. rose 1.6% to $28.65, outperforming a 0.76% S&P 500 decline, but its shares remain down 6.5% over the past month versus a 5.25% drop for the Basic Materials sector. Consensus forecasts for the October 22, 2026 earnings release call for EPS of $0.70, up 468.4% year over year, and revenue of $11.3 billion, up 13.3%. Offsetting the strong year-over-year recovery expectations, consensus EPS estimates have fallen 6.69% over the past month and the stock retains a Zacks Rank #3 (Hold).

Analysis

The relevant signal is not the single-session relative move but the mismatch between a low-looking headline valuation and deteriorating near-term expectations. For a cyclical commodity-chemical business, the earnings trough is exactly when forward P/E and PEG can be least informative: a lower denominator driven by recovery assumptions can make the stock appear optically cheap while the market discounts another leg down in polyethylene, packaging, and construction demand. The consensus reset also raises the probability that the next report becomes a credibility test on volume, utilization, and cash conversion rather than an EPS beat.

DOW's key sensitivity is the spread between North American ethane/feedstock costs and global selling prices, alongside industrial demand in Europe and China. A stronger dollar, weak European manufacturing, or further oil-price weakness would pressure export realization and delay operating-rate recovery; LYB and WLK share the broad cycle exposure, while CE is relatively more levered to engineered-materials demand. Conversely, any evidence of Chinese stimulus translating into polymers pricing, or durable improvement in European gas economics, could drive a sharp rerating because positioning appears skeptical and the equity is income-owned.

The contrarian case is that low expectations create a tradable beat setup, but this requires independent confirmation from chemical spot prices, inventory destocking, and management commentary—not analyst-model valuation metrics. The article supplies no evidence that these leading indicators have turned, so this is an earnings-event watch rather than a directional recommendation today.

Key Decisions for Investors

• No outright DOW position before the October 22 earnings release; establish an alert if consensus EPS falls another 10% or management signals lower fourth-quarter utilization, which would support a 1-3 month short DOW versus long XLB to isolate company/cycle-specific downside.
• Monitor DOW versus LYB over the next 4-8 weeks: go long DOW/short LYB only if U.S. polyethylene pricing stabilizes and DOW reaffirms cash-flow and dividend coverage. Target 8-12% relative upside on normalization; exit if DOW cuts full-year cash-flow expectations or the spread underperforms by 5%.
• For a bullish earnings setup, use defined-risk call spreads only after pre-earnings chemical pricing and estimate revisions stop deteriorating. A post-results DOW 3-month at-the-money/10%-out-of-the-money call spread offers better risk control than owning common stock into an unverified cyclical inflection.
• Avoid treating QBTS as related exposure; it is data-tag noise with no identifiable operating or valuation linkage to the chemicals thesis.